The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

Skye Bioscience currently trades essentially at cash value, meaning investors who buy in today get a weight loss drug ...

The singer and flutist hopped on Instagram Live to break down how she lost weight and what she does to ensure she focuses on ...

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

Blue Cross Blue Shield of Massachusetts says it will soon stop covering popular drugs for weight loss, like Ozempic and ...

Orforglipron, which could become the first GLP-1 pill — a much more convenient option — is a step closer to hitting the ...

The state’s largest commercial health insurer will stop covering a popular class of prescription drugs for weight loss, ...

Eli Lilly announced the results of a clinical trial for its new pill, which the company said causes nearly 8% weight loss at ...